Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients. [electronic resource]
- Investigational new drugs 10 2020
- 1463-1471 p. digital